Systemic therapies for intrahepatic cholangiocarcinoma

Intrahepatic cholangiocarcinoma (iCCA) is a highly lethal hepatobiliary neoplasm whose incidence is increasing. Largely neglected for decades as a rare malignancy and frequently misdiagnosed as carcinoma of unknown primary, considerable clinical and investigative attention has recently been focused...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of hepatology 2020-02, Vol.72 (2), p.353-363
Hauptverfasser:	Kelley, Robin Kate, Bridgewater, John, Gores, Gregory J., Zhu, Andrew X.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant therapy Checkpoint inhibitors Chemotherapy Cholangiocarcinoma Cisplatin FGFR Fibroblast growth factor receptor 2 Gemcitabine Hepatocellular carcinoma IDH Immunotherapy Malignancy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!